The deal size was increased to $140M in common stock from $125M in common stock. Leerink acted as sole book running manager for the offering.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REPL:
- Replimune announces proposed public offering of $125M of shares
- Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz
- Replimune price target raised to $18 from $14 at BMO Capital
- Closing Bell Movers: Gap jumps 15% after Q3 earnings beat, guidance raise
- Replimune Group Advances Cancer Treatment with FDA Submission